The Pancreatic Cancer Diagnostic Global Market Report 2023, provides comprehensive information on the pancreatic cancer diagnostic market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Pancreatic Cancer Diagnostic Market’s Growth:
https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-diagnostic-global-market-repor
The global pancreatic cancer diagnostic market size is expected to grow from $3.65 billion in 2022 to $3.92 billion in 2023 at a compound annual growth rate (CAGR) of 7.25%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of pancreatic cancer diagnostic market is expected to reach $5.26 billion in 2027 at a CAGR of 7.65%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=11981&type=smp
Product innovations are a key trend gaining popularity in the pancreatic cancer diagnostic market. Companies operating in the pancreatic cancer diagnostic market are adopting innovative solutions to sustain their position in the market. For instance, in March 2023, Prestige Biopharma Limited, a Singapore-based biopharmaceutical company, launched the first-in-class PAUF-detecting diagnostic kit, a powerful instrument for the early detection of pancreatic cancer. PAUF (Pancreatic Adenocarcinoma Upregulated Factor) is a unique tumor-specific biomarker associated with early metastasis and overexpression in about 80% of pancreatic cancer cases. The innovative diagnostic technique has high sensitivity and specificity for identifying PAUF. Preliminary studies showed that the expression level of PAUF in the blood plasma of pancreatic cancer patients is almost 1.9 times higher than that of healthy individuals, according to Prestige Biopharma’s IDC (Innovative Discovery Center).
The pancreatic cancer diagnostic market is segmented:
1) By Product: Instruments, Consumables, Services
2) By Treatment: Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy
3) By Cancer Type: Exocrine, Adenocarcinoma, Squamous Cell Carcinoma, Adenosquamous Carcinoma, Colloid Carcinoma, Endocrine
4) By Test Type: Imaging Test, Biopsy, Blood Test, Genomic Test, Other Test Types
5) By End-User: Hospitals, Diagnostic Centers, Cancer Research Centers, Academic Institutes, Ambulatory Surgical Centers, Other End-Users
North America was the largest region in the pancreatic cancer diagnostic market in 2022.
The table of contents in TBRC’s pancreatic cancer diagnostic market report includes:
1. Executive Summary
2. Pancreatic Cancer Diagnostic Market Characteristics
3. Pancreatic Cancer Diagnostic Market Trends And Strategies
4. Pancreatic Cancer Diagnostic Market – Macro Economic Scenario
5. Pancreatic Cancer Diagnostic Market Segmentation
.
.
.
26. South America Pancreatic Cancer Diagnostic Market
27. Brazil Pancreatic Cancer Diagnostic Market
28. Middle East Pancreatic Cancer Diagnostic Market
29. Africa Pancreatic Cancer Diagnostic Market
30. Pancreatic Cancer Diagnostic Market Competitive Landscape And Company Profiles
Top Major Players:
- Pfizer Inc
- Hitachi Medical Corporation
- F. Hoffmann-La Roche AG
- Novartis AG
- Bristol-Myers Squibb Company
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 029
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
